← All organizations
Highest phase reached
Phase 1
First clinical trial
Feb 1, 2018Last known activity
Aug 31, 2024
Timeline
2010s
- Jun 1, 2014
iCell Gene Therapeutics— Founded
Drugs by trial phase (10 distinct, 15 trials)
Indications
Studied for
- Leukemia
- Leukemia, B-Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, T-Cell
- Lymphoma
- Lymphoma, T-Cell
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasms
- Neoplasms, Plasma Cell
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Recent trials (25)
- NCT06787989Lead sponsorPhase 1Aug 31, 2024
- NCT06071624CollaboratorPhase 1Jan 31, 2024
- NCT05212584CollaboratorPhase 1Jul 1, 2022
- NCT05445765CollaboratorPhase 1Jul 1, 2022
- NCT05212584Lead sponsorPhase 1Jul 1, 2022
- NCT05445765Lead sponsorPhase 1Jul 1, 2022
- NCT05474885Lead sponsorPhase 1Apr 1, 2022
- NCT04934774CollaboratorPhase 1Dec 1, 2020
- NCT04934774Lead sponsorPhase 1Dec 1, 2020
- NCT04594135CollaboratorPhase 1Nov 30, 2020
- NCT04594135Lead sponsorPhase 1Nov 30, 2020
- NCT04162340CollaboratorPhase 1Nov 30, 2019
- NCT04162353Lead sponsorPhase 1Nov 30, 2019
- NCT04162353CollaboratorPhase 1Nov 30, 2019
- NCT04162340Lead sponsorPhase 1Nov 30, 2019
Details
- Founded
- New York, NY, US Jun 1, 2014
- Last known activity
- Aug 31, 2024